Buy JSW Steel, target Rs 348: Hadrien Mendonca
News2018-06-28
12 Views
The relative strength too seems to be bouncing before hitting the oversold zone, which further accentuates our stance of a recovery in the stock, says Hadrien Mendonca of IIFL.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Sarepta Therapeutics, Inc. (Nasdaq: SRPT) to Share Clinical Update from SRP-9003 Gene Therapy Trial to Treat Limb-girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
